FindTrial
Sign In

Prospective diagnostic study of needle and syringe sample in endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for pancreatic cancer biopsy

Prospective diagnostic study of needle and syringe sample in endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for pancreatic cancer biopsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044293
Enrollment
Unknown
Registered
2021-03-14
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Gold Standard:Histological examination or clinical outcomes.
Index test:Needle&#32
Sample&#32
and&#32
Syringe&#32
Sample

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged > 18 years; (2) Gender: both male and female; (3) Imaging examination (MRI, CT, B-mode ultrasound) showed solid pancreatic mass (>1cm in diameter), and biopsy was needed to determine the nature of the lesion; (4) Examiners in the research center; (5) Signing the informed consent; (6) Both needle and syringe sample were obtained.

Exclusion criteria

Exclusion criteria: (1) Hemoglobin 1.5, rough estimate, INR BBB>5 is equivalent to PT BBB2 1>conds); (4) Patients who have taken aspirin, warfarin and other anticoagulant drugs in the past 1 week; (5) Patients with a history of acute pancreatitis within the last 2 weeks; (6) Cardiopulmonary dysfunction, unable to tolerate endoscopic ultrasonography.

Design outcomes

Primary

MeasureTime frame
cytological diagnosis;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactYang Xiujiang

Fudan University Shanghai Cancer Center

yangxj1960@163.com+86 21-34610367

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026